{"id":"W4295836902","doi":"10.1016/j.annonc.2022.07.1521","title":"1389P Two-year follow-up of KEYNOTE-365 cohort D: Pembrolizumab (pembro) plus abiraterone acetate (abi) and prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC)","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"William Osler Health System; Sunnybrook Health Science Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Abiraterone acetate; Abiraterone; Prednisone; Pembrolizumab; Prostate cancer; Oncology; Internal medicine; Cohort; Chemotherapy; Cancer; Gynecology; Androgen deprivation therapy; Androgen receptor; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007788241,0.0004284553,0.0006638305,0.0003956757,0.0006161368,0.0009918843,0.0005684998,0.000886842,0.004455309],"category_scores_gemma":[0.001571982,0.0003798883,0.001401901,0.0006075552,0.0002116586,0.00101515,0.0006950735,0.00140055,0.0009337492],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008610623,"about_ca_system_score_gemma":0.0008700896,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01754993,"about_ca_topic_score_gemma":0.01271518,"domain_scores_codex":[0.9994435,0.00007528396,0.00004121469,0.0002034426,0.0000758439,0.0001606179],"domain_scores_gemma":[0.9991392,0.00008729468,0.0002338989,0.0001464022,0.0001446498,0.0002485684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.110723,0.002057449,0.8334444,0.0001879751,0.002877529,0.0008177352,0.0003084,0.0008221784,0.004147285,0.0001645463,0.01319726,0.03125221],"study_design_scores_gemma":[0.002562478,0.006124755,0.9833415,0.00003628449,0.0009526109,0.0003158598,0.000270477,0.0004823131,0.0005253022,0.0001345877,0.00522164,0.00003232723],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9785227,0.0007036187,0.0002629819,0.000339609,0.000135091,0.0001125543,0.01813259,0.00002760934,0.001763294],"genre_scores_gemma":[0.9789816,0.0002848548,0.0001328557,0.0003407105,0.00007466571,0.00009564437,0.0165829,0.00001244412,0.003494431],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01754993,"threshold_uncertainty_score":0.03489554,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04172470123149347,"score_gpt":0.3556152591319059,"score_spread":0.3138905579004125,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}